Company profile

Ticker
TEVA
Exchange
CEO
Kåre Schultz
Employees
Incorporated in
Location
Fiscal year end
Former names
Teva Pharmaceutical Industries Limited
SEC CIK

TEVA stock data

(
)

Calendar

7 Nov 19
20 Nov 19
31 Dec 19

News

Company financial data Financial data

Quarter (USD) Sep 19 Jun 19 Mar 19 Dec 18
Revenue 4.26B 4.34B 4.3B 4.56B
Net income -314M -689M -105M -2.89B
Diluted EPS -0.29 -0.63 -0.1 -2.85
Net profit margin -7.36% -15.89% -2.44% -63.30%
Operating income -81M -644M 134M -3.16B
Net change in cash -924M 192M 191M -93M
Cash on hand 1.24B 2.17B 1.97B 1.78B
Cost of revenue 2.44B 2.44B 2.44B 2.59B
Annual (USD) Dec 18 Dec 17 Dec 16 Dec 15
Revenue 18.85B 22.39B 21.9B 19.65B
Net income -2.15B -16.27B 329M 1.59B
Diluted EPS -2.35 -16.26 0.07 1.82
Net profit margin -11.40% -72.66% 1.50% 8.08%
Operating income -1.64B -17.48B 2.15B 3.35B
Net change in cash 819M -25M -5.96B 4.72B
Cash on hand 1.78B 963M 988M 6.95B
Cost of revenue 10.56B 11.77B 10.04B 8.3B

Financial data from company earnings reports

Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
8th grade Avg
New words: Absent, acetonide, adjourned, agai, amountsa, appealto, attention, Atto, back, Belrapzo, binding, Bisoprolol, Britishp, building, Bulgarian, buprenorphine, Carlo, certified, challe, confirmed, consistedo, coun, Cuyahoga, decisionso, departure, Drap, endedSeptember, eneral, equ, Eric, financiala, firstnine, framework, fumarate, ge, grand, Hong, hydrochlorothiazide, inAugust, inquiry, Ivermectin, Janssendid, Justice, Kalif, Kong, labor, lev, lotion, Mark, McClellan, Michael, Michigan, mL, naloxone, nationwide, neric, Notaristefani, nst, ofa, people, predicated, Pregabalin, rney, RUB, Sabag, Schultz, stage, stepped, sublingual, Suboxone, suffering, Summit, tangible, Tennessee, thee, thenine, thesettlement, thethird, thisquarterly, Treprostinil, Triamcinolone, uble, upply, uro, Vice, whichwere, withholding, wouldprovide
Removed: Aloxi, complying, deny, distributor, enactment, endpoint, FASB, forint, grant, Hungarian, judge, lira, nuisance, primary, proposed, recommendation, recommended, RediHaler, stay, study, Turkish